The differences between the Federal Circuit’s most-reversed and least-reversed district courts run far deeper than their success rates on appeal — a metric that can vary widely throughout the judiciary, according to Law360’s look at three years of Federal Circuit cases.
Legislation creating so-called “Rocket Dockets” to speed up patent cases and reduce reversal rates on appeal eased through a Congressional markup Thursday after concerns about possible forum shopping were addressed.
Owners of trademarks and related publicity rights are chalking up another victory after a federal appeals court ruled recently that licensees couldn’t assign those rights to third parties without the licensor’s express permission.
A bottleneck at the USPTO is stunting growth in IP for nanotechnology, creating an air of uncertainty about what’s expected to be a wave of patent litigation in the industry.
A New York arbitration panel has ruled that LG Philips LCD Co. holds the exclusive ownership rights to numerous side-mounting patents, a decision that could help the company in its pending patent dispute with Chunghwa Picture Tubes.
Upsher-Smith Laboratories Inc. and Unigene Laboratories Inc. have targeted generic pharmaceutical maker Apotex Inc. and its U.S. unit in a patent infringement suit for attempting to break into the nasal spray market with a generic version of Fortical.
A Missouri company has filed a lawsuit against a laser eye surgery rival, asking a federal judge to rule that it is not infringing on its rival’s patent.
The battle over DRAM technology continues to escalate, with chipmaker Micron Technology Inc. firing off a lawsuit seeking to invalidate 14 patents held by rival company Mosaid Technologies Inc.
The University of Berne in Switzerland announced Monday that it has sued Synthes AG for patenting a spine surgery technique invented by one of its researchers.
A former employee of rental car company Avis Group Holdings Inc. backdated a spreadsheet software program and then wrongly sued the company for copyright infringement, a federal judge ruled Thursday.
The long-running patent feud between wireless companies Boston Communications Group and Freedom Wireless is expected to draw to a close soon, after bcgi agreed to pay $55.3 million to settle allegations of patent infringement.
Music industry giant Sony BMG has been hit with an amended complaint in a suit that challenges how the music industry assesses royalties for musicians who signed contracts before the dawn of digital downloads.
U.S. state attorneys general will rule on the second update of Bristol-Myers Squibb, Sanofi-Aventis and Apotex’s settlement agreement over the patent for generic Plavix within the next week.
Amgen Inc., the largest biotechnology company in the world, reiterated Thursday that it will continue legal action against Roche Holding AG for alleged infringement of the patents to a pair of blockbuster anemia drugs.
Three U.S. Senators introduced a bill Thursday that would prohibit brand-name drugmakers from marketing generic versions of their drugs, claiming the practice undermines competition and runs contrary to congressional intent for generic market exclusivity.
Brinks Hofer Gilson & Lione has expanded its intellectual property law practice with the opening of a Salt Lake City office and has pulled in two new attorneys to bolster the practice in its new location.
Diazyme Laboratories, the life sciences division of California-based General Atomics, has won a summary judgment of noninfringement in its legal battle with a European company over a patent for enzymatic homocysteine tests.
After hearing closing arguments on Wednesday, a Manhattan district court judge must now decide whether three Israeli scientists should be named co-inventors of the blockbuster cancer drug Erbitux.
Bankrupt hedge fund manager PlusFunds Group Inc. has sued Standard & Poor’s, alleging the popular financial data publisher breached a license agreement when it axed its hedge fund index that was stocked with PlusFunds’ data.
Just days after a federal court issued a Markman ruling in a drawn-out patent battle between Enzo Biochem Inc. and a group of rival biotech companies, Roche Molecular Diagnostics said Friday that the ruling is in its favor, despite Enzo’s earlier claims to the contrary.
Chip maker Micron Technologies Inc. is shelling out $30 million to settle a patent dispute with rival Tessera Technologies Inc., which accused the company of infringing its technology for semiconductor packaging.